Woloszczuk-Gebicka Bogumila, Wyska Elzbieta, Grabowski Tomasz, Swierczewska Anna, Sawicka Renata
Department of Anaesthesiology and Intensive Therapy, Children's Memorial Health Institute, Warsaw, Poland.
Paediatr Anaesth. 2006 Jul;16(7):761-8. doi: 10.1111/j.1460-9592.2005.01840.x.
The aim of this study was to compare pharmacokinetics and pharmacokinetic-pharmacodynamic (PK-PD) relationship of rocuronium in children anesthetized with nitrous oxide (N2O) and fentanyl or with N2O and sevoflurane.
Twenty-four children (3-11 years old, ASA PS I or II) were randomized to receive N2O/O2-fentanyl or N2O/O2-sevoflurane (one MAC) anesthesia. Neuromuscular transmission was monitored electromyographically. Initial bolus dose of rocuronium, 0.6 mg x kg(-1) was followed by continuous infusion, targeting at steady-state 95% T1 depression. Neuromuscular transmission was allowed to recover spontaneously. Plasma samples were collected at the moment of discontinuation of infusion, and 10, 20, 30, 50, 60 and 75 min afterwards. Concentrations of rocuronium were measured using high-performance liquid chromatography with electrochemical detection (HPLC-EC). Rocuronium PK was described by a two-compartment model and PD parameters were estimated using effect compartment and sigmoidal E(max) models.
No differences in rocuronium PK parameters were observed between study groups. Clearance was 3.91 +/- 2.07 and 3.62 +/- 0.80 ml x min(-1) x kg(-1) in sevoflurane and fentanyl groups, respectively (P < 0.65). Effect compartment concentrations corresponding to 50% inhibition of T1 (EC50) were 1.41 +/- 0.45 and 2.32 +/- 1.00 microg x ml(-1) (P < 0.02), and rate constants for equilibration between plasma and effect compartment (k(e0)) values were 0.10 +/- 0.04 and 0.24 +/- 0.14 min(-1) (P < 0.009) in sevoflurane and fentanyl groups, respectively.
Disposition of rocuronium was similar under stable N2O-fentanyl and N2O-sevoflurane anesthesia. Sevoflurane reduced rocuronium requirements as well as decreased EC50 relevant to inhibition of T1 and rocuronium transfer to effect compartment. Therefore, the potentiating effect of sevoflurane seems to be mainly of PD origin, probably due to an increased sensitivity of the neuromuscular junction.
本研究旨在比较在接受氧化亚氮(N₂O)和芬太尼麻醉或N₂O和七氟醚麻醉的儿童中罗库溴铵的药代动力学及药代动力学-药效学(PK-PD)关系。
24名儿童(3 - 11岁,美国麻醉医师协会身体状况分级I或II级)被随机分为接受N₂O/氧气-芬太尼或N₂O/氧气-七氟醚(一个最低肺泡有效浓度)麻醉。通过肌电图监测神经肌肉传递。罗库溴铵初始推注剂量为0.6 mg·kg⁻¹,随后持续输注,目标是达到稳态95%的T₁抑制。让神经肌肉传递自发恢复。在输注停止时以及之后10、20、30、50、60和75分钟采集血浆样本。使用高效液相色谱-电化学检测法(HPLC-EC)测定罗库溴铵浓度。罗库溴铵的药代动力学用二室模型描述,药效学参数使用效应室和S型E(max)模型估算。
研究组之间罗库溴铵的药代动力学参数未观察到差异。七氟醚组和芬太尼组的清除率分别为3.91±2.07和3.62±0.80 ml·min⁻¹·kg⁻¹(P<0.65)。对应于T₁抑制50%的效应室浓度(EC₅₀)分别为1.41±0.45和2.32±1.00 μg·ml⁻¹(P<0.02),七氟醚组和芬太尼组血浆与效应室之间的平衡速率常数(k(e0))值分别为0.10±0.04和0.24±0.14 min⁻¹(P<0.009)。
在稳定的N₂O-芬太尼和N₂O-七氟醚麻醉下,罗库溴铵的处置相似。七氟醚降低了罗库溴铵的需求量,并降低了与T₁抑制相关的EC₅₀以及罗库溴铵向效应室的转移。因此,七氟醚的增强作用似乎主要源于药效学,可能是由于神经肌肉接头的敏感性增加。